A 2023 study out of the University of British Columbia linked GLP-1 agonists to a heightened risk of severe gastrointestinal problems. These problems include gastroparesis, pancreatitis, and bowel obstruction
Strength training does not need to feel intimidating
Wilson L, Pollard AE, Penfold L, Muckett PJ, Whilding C, Bohlooly-Y M, Wilson P, Carling D (2021) Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype
GLP-1 Receptor Agonist Use Is Associated with Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth
It's important to recognize red flags that suggest you should seek professional help from a registered dietitian, therapist, or healthcare provider